阳光诺和：与星浩控股签署STC008注射液技术开发合同

Core Viewpoint - The company, Sunlight Nuohe (688621.SH), has signed a technology development contract with Zhejiang Xinghao Holding Partnership (Limited Partnership) to jointly develop the STC008 injection project, which is expected to positively impact the company's future performance and enhance profitability [1] Financial Summary - The company will receive an initial payment of 50 million yuan and subsequent milestone payments, totaling 500 million yuan (including tax), along with an 8% share of net sales [1] Project Status - The STC008 project is currently in Phase I clinical trials, indicating a long development cycle and multiple risks related to the research and market environment [1]